Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kath Kerry

- PMLiVE

South African variant reduces antibody levels produced by Pifzer/BioNTech’s COVID-19 vaccine

Researchers noted it is 'unclear' what effect this reduction has on the vaccine's protection against the variant

- PMLiVE

akt health communications hires Heather Tarplee as senior account director

Prior to joining akt health, Tarplee worked at Freuds for five years

- PMLiVE

AI and accelerated computing ring in new era for healthcare

The AI trends set to dominate healthcare in 2021

- PMLiVE

HCA releases new PR media guide

The guide aims to help healthcare PR professionals understand how best to approach journalists

- PMLiVE

Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy

Project will aim to discover and develop a gene therapy for sickle cell disease

Pandemics for dummies

The mistakes are plentiful, but one stands out as most egregious

- PMLiVE

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

Initial stage of the study will involve up to 90 healthy adult volunteers who will be exposed to COVID-19

- PMLiVE

GSK launches late-stage testing of RSV vaccine candidate in older adults

Vaccine candidate was found to be well-tolerated in a phase 1/2 trial

- PMLiVE

J&J applies for EU authorisation for one-dose COVID-19 vaccine

Submission is based on top-line efficacy and safety data from the phase 3 ENSEMBLE trial

Onyx Health Targets Digital Growth with New Executive Director

Healthcare marketing communications agency Onyx Health have appointed Trevor Pill as their new Executive Director

Onyx Health

- PMLiVE

Three strategies for managing loss of exclusivity successfully

Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.

Blue Latitude Health

- PMLiVE

bluebird bio temporarily suspends trials of sickle cell gene therapy LentiGlobin

Company will also suspend marketing of beta-thalassemia gene therapy Zynteglo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links